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The lipid cofactor requirement of hepatic monoacyl- 
glycerol acyltransferase (MGAT) (EC 2.3.1.22)  was stud- 
ied in Triton X-100Aipid-mixed  micelles.  Anionic  phos- 
pholipids and anionic lysophospholipids stimulated 
MGAT activity, whereas fatty acids and sphingosine in- 
hibited enzyme  activity. Phosphatidic acid was a potent 
activator, stimulating MGAT 11-fold at 4.2 mol %. Kinetic 
studies revealed that phosphatidic acid, with an  appar- 
ent K,, of  0.26  mol %, was a better activator than phos- 
phatidylserine, phosphatidylinositol, or cardiolipin. Of 
the anionic lysophospholipids, lysophosphatidic acid 
was a better activator than lysophosphatidylserine, 
stimulating maximally at less than 3 mol %. Oleate  was a 
more potent inhibitor (Ki, 2.4 mol %) than sphingosine 
(Ki, 18.3  mol %). The dependence of  MGAT on Sn-2-mOnO- 
acylglycerol  was not cooperative in  the absence or pres- 
ence of anionic phospholipids,  oleic acid, or sphingo- 
sine.  The apparent K,,, for sn-~-rnono~~8:~-g~ycero~ was 
1.24 mol % in  the presence of maximally activating phos- 
pholipid and 0.19 mol % when  phospholipid  was  omitted. 
MGAT's product sn-1,2-diacylglycer01  was a weaker ac- 
tivator than  the anionic phospholipids, but the effects of 
diacylglycerol and phospholipid  were  additive.  Activa- 
tion by sn-l,2-diC18l-glycerol was highly cooperative 
with a Hill coefficient of  3.6. Activation  was  specific for 
the sn-l,2-stereoisomer; neither 1,3-diacylglycerol nor 
the  ether analogs of sn-l,2- or 1,3-diacylglycerol  were 
activators. Since several of the lipid modulators of 
MGAT activity are intracellular second messengers, 
these data suggest the possibility that regulatory links 
exist  between signal transduction and the synthesis of 
complex lipids via the monoacylglycerol  pathway. 
~~ 
Rat  hepatic monoacylglycerol acyltransferase (EC 2.3.1.22) 
(MGAT)' is a developmentally expressed microsomal enzyme 
whose specific activity in  suckling rats is as much as 700-fold 
higher  than  the  activity  in  adults (1).The enzyme catalyzes  the 
stereospecific synthesis of sn-1,2-diacylglycerol from sn-2- 
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monoacylglycerol and long chain  fatty acyl coenzyme As (1, 2). 
MGAT may play an  important role in  regulating glycerolipid 
synthesis because its sn-2-monoacylglycerol substrate  is a com- 
petitive inhibitor of glycerol-3-phosphate acyltransferase (3) 
and diacylglycerol kinase (4) and because its sn-l,2-diacylglyc- 
erol product is both an intermediate in phospholipid and 
triacylglycerol synthesis  and an  activator of protein  kinase C. 
Hepatic MGAT has an increased affinity for sn-2-monoacyl- 
glycerols that contain  polyunsaturated acyl chains  (5,6).  Thus, 
the  high MGAT activity observed in  liver from neonatal rats, 
hibernating  marmots, developing chick embryo, and streptozo- 
tocin-induced diabetic rats (5, 7) may function to retain  essen- 
tial fatty acids during physiologic periods characterized by 
massive lipolysis. MGAT also  has  an  inferred role in diacyl- 
glycerol-mediated signal  transduction  pathways (8, 9) and  in 
the incorporation of xenobiotic acids  into glycerolipids (10, 11). 
In  the  intestine, MGAT provides a  major route for the  synthesis 
of chylomicra  triacylglycerol(l2-14).  Despite the  importance of 
MGAT in hepatic and intestinal lipid metabolism, little is 
known about  the enzyme's structure  and  regulation. 
Detailed characterization of enzymes like MGAT that  syn- 
thesize glycerolipids has been  limited. These enzymes are  in- 
tegral membrane  proteins  and difficult to  study because their 
substrates  and  products  are hydrophobic or amphipathic.  En- 
zyme assays that use organic  solvents to  disperse hydrophobic 
constituents typically involve nonhomogeneous mixtures of en- 
zyme, activators,  substrates,  and phospholipids  which render 
kinetic  analyses problematic. Many of these difflculties can be 
overcome by the  use of detergentJphospholipid-mixed micellar 
assays.  Such  assays  have b en used successfully to  examine  the 
lipid and ion dependencies of several membrane-bound en- 
zymes (15,16; for review, see Ref. 17). Use of the mixed micellar 
assay allows one  to  manipulate  the  concentrations of enzyme, 
substrate,  and lipid in a precisely defined environment  that 
obeys surface  dilution  kinetics (18). 
We employed mixed micellar assays  in  order  to  determine 
whether MGAT activity  has an  absolute  requirement for  lipids, 
to define the stoichiometry and specificity of the lipid require- 
ment,  and  to  elucidate  the  mechanism of the lipid  dependence. 
We found that negatively charged phospholipids and sn-1,2- 
diacylglycerol activated MGAT and  that  fatty  acids  and  sphin- 
gosine inhibited MGAT activity. These  results  suggest  the pos- 
sibility that  regulatory  links  exist between signal  transduction 
and  the  synthesis of complex lipids via  the monoacylglycerol 
pathway. 
EXPERIMENTAL PROCEDURES 
Materials-All chemicals were reagent grade. Phosphatidic acid 
(from egg lecithin), dioleoylphosphatidylcholine, phosphatidylcholine 
(pig  liver),  phosphatidylserine  (beef brain), phosphatidylethanolamine 
(pig liver), phosphatidylinositol (pig liver),  lysophosphatidic acid (from 
egg lecithin), dioleoylphosphatidylglycerol, lysophosphatidylcholine 
(pig liver),  lysophosphatidylserine (beef brain), diCl8:l phosphatidyl- 
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glycerol, lysophosphatidylethanolamine (pig liver), sphingomyelin (beef 
brain), ceramide (beef brain),  neutral lipids, cerebroside (beef brain), 
cardiolipin (beef heart), fatty acids, and sphingosine (beef brain) were 
purchased from Serdary Research Laboratories, Inc. DiC18:l-phos- 
phatidylserine, diC4:O-phosphatidic  acid,  diC14:O-phosphatidic  acid, 
and diC18:2-phosphatic acid  were  from  Avanti Polar Lipids. BSA (es- 
sentially fatty acid free), Triton X-100,  DTT,  EDTA,  L-glycerol 3-phos- 
phate, dihydroxyacetone phosphate, and CM-Sepharose FF were  from 
Sigma. QAE-Sephadex and hydroxylapatite (Bio-Gel HTP) were from 
Pharmacia LKB Biotechnology Inc. and Bio-Rad, respectively. Thin 
layer chromatography plates were  from Analtech. 
Partial Purification of MGAT-Animal use was  approved by the Ani- 
mal Care Committee of University of North Carolina. Pregnant 
Sprague-Dawley rats were obtained from  Zivic-Miller and housed in the 
University of North Carolina animal facility under controlled  12-h light 
cycles with free access to  food and water. Within 24 h  after  birth, each 
litter was culled to a maximum of 12 pups. On the 11th day after  birth, 
KC1-washed liver microsomes  were prepared and stored at -70 "C (6). 
Microsomes were solubilized with 0.3% Triton X-100, and MGAT was 
purified by sequential chromatography with QAE-Sephadex, CM- 
Sepharose (Fast Flow), and hydroxylapatite (6). Further steps with 
hexyl-coenzyme A-agarose and Sephacryl S-200 chromatography re- 
sulted in purification of MGAT to apparent homogeneity.  However,  be- 
cause the final purification steps required transfer into CHAPS  which 
inhibited more than 90% of the enzyme activity (data not shown), we 
studied MGAT's lipid  dependence with preparations purified only 
through the hydroxylapatite step. To determine whether the hydrox- 
ylapatite-purified enzyme preparation contained phospholipids, mate- 
rial was extracted into CHC1, and phospholipids  were separated by thin 
layer chromatography on Silica Gel G plates in heptane/isopropyl ether/ 
acetic acid (60:40:4 (vh)). The material remaining at  the origin was 
eluted three times with CHClJmethanol  (1:2 (v/v)), and phospholipid 
was quantified by measuring inorganic phosphorous  following  perchlo- 
ric acid digestion (19). No phosphate was detected in either of two 
independent enzyme preparations 
The solubilized  enzyme preparation was stored in aliquots a t  -70 "C 
in  a buffer containing 20%  glycerol, 5% ethylene glycol,  20 nm MES,  pH 
6.5, 1 m~ EDTA, 1 m~ DTT, 0.1 m~ phenylmethylsulfonyl fluoride, 1 
pg/ml pepstatin, 0.5 m~ benzamidine, 0.2% Triton X-100, and 0.2 M 
NaCl. Hydroxylapatite-purified MGAT specific activities were 1443, 
1422,  1423, and 2341  nmol/min/mg  from four different purified prepa- 
rations when MGAT was assayed in a 0.2-ml reaction mixture contain- 
ing 100 m~ Tris-C1,  pH 8 , l  mg/ml  BSA,  450  pg/ml sonicated  microsomal 
lipids, 150 p~ sn-2-monoC18:l-glycerol and 300 p~ sn-1,2-diC18:l-glyc- 
erol dispersed together in 10 pl of acetone, 5 m~ DTT,  2.5 m~ EDTA,  25 
p~ [3H]palmitoyl-coenzyme A (66 Ci/mol), and 0.1-0.5  pg  of protein (6). 
MGAT  Mixed Micellar Assay-Stock solutions (stored in chloroform 
or hexane) of the different lipids employed  were dried under a  stream of 
nitrogen in  a glass tube and solubilized in Triton X-100  by vortex  mixing 
and brief sonication in  a water bath at room temperature. Required 
amounts of lipids were then added to the reaction mixture. MGAT 
activity was assayed at 23 "C in  a 0.2-ml reaction mixture that con- 
tained 100 nm Tris-C1,  pH 7.0,0.5 mg/ml  BSA, 150 w sn-2-monoC18:l- 
glycerol, 0.22% Triton X-100 (3 m~ micelle concentration): 25 p~ 
[3Hlpalmitoyl-CoA, 0.25-0.5 pg of hydroxylapatite-purified protein, and 
the indicated concentrations of specific  phospholipids.  After a 10-min 
incubation, the products were extracted into heptane, and an aliquot 
was counted (20). For  some studies, the remaining portion of the hep- 
tane extract was concentrated in a  Savant Speedvac concentrator and 
chromatographed with camer lipids on a 10-cm  Silica  Gel G plate in 
heptane/isopropyl ethedacetic acid  (60:40:4 (v/v)). Lipids  were visual- 
ized  by exposure to I, vapor, and the  areas corresponding to diacylglyc- 
erol and triacylglycerol  were scraped and counted.  Because  more than 
97% of the labeled product was diacylglycerol, thin layer chromatogra- 
phy was not routinely performed. All assays contained optimal amounts 
of sn-2-monoC18:l-glycerol and [3Hlpalmitoyl-CoAand measured initial 
rates. For each study reported, data  are shown for a representative 
experiment that was repeated two to six times using two to four  differ- 
ent microsomal preparations. 
Other Methods-F'rotein was measured by the method of Lowry et al. 
(21) with BSA as  the standard. When the samples contained Triton 
X-100, protein was precipitated with 10% trichloroacetic acid before 
protein was measured. sn-1,2-DiC18:l-Glycerol and sn-1,3-diC18:1- 
For purposes of calculating mole fractions, the aqueous monomeric 
concentration of Triton X-100, (0.3 m ~ ) ,  was subtracted from the total 
detergent concentration. Final concentrations include the Triton X-100 
that is added together with the purified enzyme. 
1000 I I . + PC, Ps 
o-pc,Ps 
I I 
0 1 4 6 8 
[Triton X-1001 m M  
FIG. 1. Effect of Triton X-100 concentration  on MGAT reaction 
velocity. The concentration of Triton X-100 in the reaction mixture was 
varied as shown,  while the concentration of sn-2-monoC18:l-glycerol 
was maintained at 150 p ~ .  To show the concentration of Triton X-100 in 
micelles, the monomeric Triton X-100 concentration in the aqueous 
phase (0.3 m ~ )  was subtracted. 
glycerol  were separated on  20-cm  3% borate Silica  Gel G plates 
and chromatographed with chlorofodacetone/methanol/acetic acid 
(90:5:2:0.5, v/v).  After being scraped from the plates, the diacylglycerols 
were quantified colorimetrically (22). [3HlPalmitoyl-CoA was synthe- 
sized enzymatically (23). Kinetic constants for MGAT activity were 
obtained from linear regression analysis of double-reciprocal plots (24). 
Hill constants were calculated as described (25). 
RESULTS 
MGAT Activity in  niton X-100-mixed Micelles-Triton 
X-100-mixed micelles were used  to provide an  inert surface in 
which hydrophobic substrates and potential lipid activators 
and  inhibitors were  dispersed in physically defined amounts, 
thereby providing a matrix  that mimics the microsomal mem- 
brane bilayer. Compared with  other  detergents  tested, Triton 
X-100 inhibits MGAT activity least and is most effective in 
solubilizing MGAT activity (6). The  average  number of lipid 
molecules present  in a mixed micelle was  estimated from the 
detergent aggregation number of 140 for Triton X-100 and  the 
mol % concentration of the lipid present (17). 
To determine the optimal detergent concentration for the 
mixed micelle assays, we measured MGAT activity at Triton 
X-100 concentrations ranging from 0.2 to 8 I" (with  the mono- 
mer concentration subtracted), both in  the presence and  ab- 
sence of added phosphatidylcholine and phosphatidylserine, 
each at 112.5 pg/ml. We chose this phospholipid combination as 
the  standard  activator because it had previously been routinely 
used to  stimulate both intestinal  and  neonatal  hepatic MGAT 
activities in microsomes (12, 19).  In  the absence of phospho- 
lipid,  Triton X-100 inhibited MGAT activity at all concentra- 
tions tested;  when phospholipid was present, enzyme  activity 
was  stabilized at a Triton X-100 concentration of less than 1.75 
m~ (Fig. 1). Thus, phospholipids stimulated MGAT activity and 
also  reduced the inhibition of the enzyme by Triton X-100. A 
Triton X-100 concentration of 3 mM was chosen for all subse- 
quent experiments.  This  concentration inhibits MGAT activity 
less than 50% and provides sufficient micelles to  ensure  the 
presence of less  than a single MGAT proteidmicelle. DlT  and 
EDTA, which increase MGAT activity in a non-micellar assay 
(61, had no effect on MGAT activity in micelles, and were omit- 
ted. The  divalent cations, M e ,  Ca2+,  Ba2+, Zn2+, and Mn", did 
not  alter activity. BSA at 0.5 mg/ml increased basal enzyme 
activity 233% (data  not shown) and  was routinely  included. In 
the absence of added  lipids, BSA did not  stimulate MGAT ac- 
tivity. These modifications resulted in an  assay which was pro- 
portional to the  amount of protein  added to 0.75 pg  and with 
time  to 20 min  when 0.3  pg of protein  was present  (data not 
shown). 
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FIG. 2. Effect of phospholipids (A) and lysophospholipids ( B )  
on MGAT activity in Triton  X-100-mixed micelles. MGAT activity 
was measured in  the presence of the indicated mole fractions of phos- 
pholipids. The concentrations of Triton X-100 and sn-2-monoC18:l-glyc- 
erol  were 3 m~ and 150 p ~ ,  respectively.  Control  specific activity ob- 
tained in the absence of added lipids was 46.7 nmoVmidmg. PC, 
phosphatidylcholine; PS, phosphatidylserine; PE, phosphatidylethano- 
lamine; PA, phosphatidic acid; PI, phosphatidylinositol; SM, sphingo- 
myelin; CL, cardiolipin; LPA, lysophosphatidic acid; LPS, lysophos- 
phatidylserine; LPC, lysophosphatidylcholine; LPE, lysophos- 
phatidylethanolamine. 
Phospholipid Cofactor Dependence-Since several phospho- 
lipids had previously been shown to  stimulate MGAT activity 
in microsomes, we tested  the ability of a variety of phospholip- 
ids  to  activate MGAT. In  order  to  ensure  that  the  structure of 
the mixed micelles was similar to the structure of micelles 
composed of Triton X-100 alone (26, 27), the  total lipid concen- 
tration  used  in Triton X-100/phospholipid-mixed micelles did 
not exceed 18 mol %. At this concentration, micelle size is 
constant (26, 27). 
Phospholipids that  had  been purified from natural sources 
(see  “Experimental Procedures”)  were tested individually (Fig. 
2 A ) .  The most potent  activator  was phosphatidic acid. As little 
as 0.4 mol % of phosphatidic acid activated MGAT 5-fold. At 4.2 
mol %, phosphatidic acid activated MGAT 11-fold. Thus,  initial 
activation was observed with a single molecule of phosphatidic 
acidmicelle  whereas full  activation required  about six 
moleculedmicelle. Other anionic phospholipids at low concen- 
trations also stimulated MGAT activity. Cardiolipin and phos- 
phatidylserine at 5.1 and 7.5 mol %, respectively, activated 
MGAT 7.7- and 10.8-fold. Phosphatidylinositol at 15.5 mol % 
stimulated enzyme activity to the same extent as phospha- 
tidylserine. Synthetic diC18:l-phosphatidylglycerol stimulated 
MGAT activity 3.5-fold at 3.8 mol % with a pattern  similar  to 
that of phosphatidylserine (data not shown). Thus,  the anionic 
phospholipids obtained from natural sources stimulated MGAT 
activity between 5- and 11-fold. Maximal stimulation with 
phosphatidic  acid,  cardiolipin, and phosphatidylserine oc- 
curred  with  6, 7, and 10 molecules of the respective 
phospholipidmicelle. Only phosphatidylinositol required more 
than 22 molecules/micelle to  stimulate MGAT maximally. In 
contrast,  the zwitterionic phospholipids, phosphatidylcholine, 
phosphatidylethanolamine, and sphingomyelin  were poor acti- 
vators, requiring concentrations greater than 17 mol % to 
stimulate MGAT  4.5-5-fold. 
To determine  whether  the acyl chains were needed for activ- 
ity, we tested  the ability of glycerol 3-phosphate and dihydroxy- 
acetonephosphate and of specific lysophospholipids to activate 
MGAT. The water-soluble molecules did not  alter MGAT activ- 
ity  (data not  shown), suggesting  that  activators  must be able to 
associate  with micelles and, therefore, must be amphipathic or 
hydrophobic. The effect of added  lysophosphatidic acid and ly- 
sophosphatidylserine  was similar  to  the effect of phosphatidic 
acid and phosphatidylserine  (Fig. 2 B ) .  Basal activity was 
stimulated 7- and 5-fold with 2.7 and 10.8 mol % of added 
lysophosphatidic  acid and lysophosphatidylserine, respectively. 
In  contrast,  the zwitterionic lysophospholipids were less  potent 
than  their diacyl counterparts. Neither lysophosphatidylcho- 
line nor lysophosphatidylethanolamine activated MGAT activ- 
ity, even at concentrations as high as 11 mol %. 
In order to  test  the specificity of the phospholipid acyl chain 
composition, synthetic phosphatidylcholines of known compo- 
sition  were employed. When diC18:l-, diC18:2-, diC18:3-, and 
diC20:4-phosphatidylcholines were compared, the acyl chain 
length  and degree of saturation  had  little effect on the ability of 
phosphatidylcholine to  stimulate MGAT activity  (Fig. 3A). The 
extent of stimulation by each of the  synthetic phosphatidylcho- 
lines was similar to that observed with phosphatidylcholine 
purified from pig liver (Fig. 2 A ) .  Conversely, when we com- 
pared different synthetic phospholipids whose acyl chain com- 
position was  identical (Fig. 3B), phosphatidic acid and 
phosphatidylserine stimulated MGAT activity whereas phos- 
phatidylethanolamine and phosphatidylcholine had little ef- 
fect. These  results were similar  to  the  studies of the  natural 
phospholipids (Fig. 2 A ) .  Thus, both the concentration  depend- 
encies and  the  relative ability of each  species to activate MGAT 
indicate a high degree of specificity for anionic phospholipids 
(Fig. 2, A and B) .  Fig. 3C shows the effect of synthetic phos- 
phatidic acids of known acyl composition. The effect of both 
diC18:l-phosphatidic acid and diC18:2-phosphatidic acid on 
MGAT activity was  similar to that of natural phosphatidic acid 
from egg lecithin  (Fig. 2A) .  The maximum stimulation by these 
two lipids was approximately 4.8-fold at 2.2 mol %. DiC14:O- 
phosphatidic acid activated MGAT maximally (4.4-fold) at 9.4 
mol %. DiC4:O-phosphatidic acid had  the  least  stimulatory ef- 
fect with only a 1.9-fold increase in enzyme  activity at 4.6 mol 
%. Since the highly water-soluble diC4:O-phosphatidic acid 
stimulated MGAT activity  very little, activation appears  to  re- 
quire the presence of phosphatidic acid within the micelle. 
These data (Figs. 2 and 3) strongly suggest  that MGAT activa- 
tion depends critically on the phospholipid head group. Activa- 
tion is affected little, if any, by the degree of saturation or the 
chain  length of the acyl groups, although at least one acyl chain 
is required  to anchor the anionic phospholipid head  group  in 
the micelle. These  results also suggest  that  membrane fluidity 
would not  alter MGAT activity  substantially. 
Effect of Diacylglycerol on  MGATActiuity-In a non-micellar 
assay, hepatic microsomal lipids and sn-l,2-diacylglycerol 
stimulate MGAT approximately 2-fold (6). We wondered, there- 
fore, whether sn-l,2-diacylglycerol might be a specific activator 
of the enzyme. When phospholipids were absent, added  sn-1,2- 
diC18:l-glycerol at 18.7 mol % stimulated MGAT activity 5-fold 
(Fig. 4A). No activation occurred when less  than 11 mol % of 
diC18:l-glycerol was present (15 molecules/micelle). Ninety- 
one % of the labeled  product  was diacylglycerol, and no activity 
was detected  when 1,2-diacylglycerol was added in  the absence 
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FIG. 3. Effect of different  phospholipid  head  groups  and  acyl 
chains  on MGAT activity  in Triton  X-100-mixed  micelles. MGAT 
activity was measured in the presence of the indicated mole fractions of 
phosphatidylcholines with different acyl chains as indicated ( A ) ,  differ- 
ent phospholipids that all contained oleate in both the sn-1- and the 
sn-2- positions ( B  1, and phosphatidic acid with different acyl chains as 
indicated ( C ) .  Control  specific activity obtained in the absence of added 
phospholipid  was  52.2  nmoUmidmg. PC, phosphatidylcholine; PS,  
phosphatidylserine; PE, phosphatidylethanolamine; PA, phosphatidic 
acid. 
of sn-2-monoCl8:l-glycerol, indicating that the  added diacyl- 
glycerol was  not  being  used as a substrate. 
Activation of MGAT was specific for the  sn-l,2-stereoisomer; 
neither sn-1,3-diC18:l-glycerol nor the ether  analogs of sn-1,2- 
or 1,3-diC18:l-glycerol activated  enzyme  activity  (Fig. 4A). Ac- 
tivation by sn-l,2-diClS:l-glycerol  was highly  cooperative with 
a calculated  Hill  constant of 3.6. In  the  absence of phospholipid, 
diacylglycerol activated maximally when more than 30 mol- 
ecules were  present  per micelle. In  contrast,  when fully acti- 
vating  amounts of phosphatidylcholine and  phosphatidylserine 
were present, a low concentration of sn-1,2-diC18:l-glycerol 
could double MGAT activity (Fig. 4B). Maximal activation oc- 
curred at 6 mol %. Little  activation occurred when  less  than 2.3 
600 
4 0 0  
A 
0 1.2 DO 
0 1,3 DO 
A 1,2 DOE 
200 - A 1,3 DOE 
0 
0 10 20 30 
Lipid (Mol%) 
0 4 8 1 2   1 6  20 
sn-1.2 Dioleoylglycerol (Mol%) 
FIG. 4. Effect of diradylglycerols  on MGAT activity  in  Triton 
X-100-mixed  micelles. The concentration of diradylglycerols in the 
MGAT reaction mixture was varied as shown. A, effect of diradylglyc- 
erols in  the absence of added phospholipid. B ,  activation of  MGAT after 
maximal activation by phosphatidylcholine plus phosphatidylserine 
(1:l; 8.2 mol %). 1,2-D0, sn-1,2-diC18:l-glycerol; 1,3-D0, 1,3-diC18:1- 
glycerol; 1,2-D0E, sn-1,2-diC18:l-glycerol ether; 1,3-D0E, 1,3-diC18:1- 
glycerol ether. 
mol % of diC18:l-glycerol was  present. 
Effect of Neutral Lipids, Fatty Acids, and  Sphingosine on 
MGAT Activity-In order to determine whether other non- 
phospholipid constituents of the microsomal membrane  might 
be activators, we examined  the effects on MGAT activity of a 
variety of neutral lipids and sphingolipids. The addition of 
triC18:l-glycerol and cholesterol oleate (Fig. 51, and  ceramides, 
cerebrosides, and cholesterol (data not shown) at concentra- 
tions as high as 40 mol % inhibited MGAT activity less  than 
30%. Oleic acid had a biphasic effect; when  present at 5.3 mol 
%, it stimulated MGAT activity 1.6-fold, but at 18.4 mol %, it 
inhibited  the activity 97% (Fig. 5). Inhibition by linoleic acid, 
linolenic  acid, and  arachidonic acid was  similar to that of oleic 
acid (data not  shown).  Sphingosine was  also a potent  inhibitor 
of MGAT activity. At 17.5 mol %, sphingosine  inhibited MGAT 
activity 93%. This  inhibition  was  not  merely  due  to  counteract- 
ing  the  charge of the anionic  phospholipids;  sphingosine inhib- 
ited  equally well in the presence of activating  concentrations of 
diacylglycerol (data  not  shown) or when no activating phospho- 
lipid was  present. 
Effect of Phospholipid Activators  on  the  Kinetics of MGAT 
Activity-In order  to  understand  the  mechanism of phospho- 
lipid activation, the monoacylglycerol dependence of MGAT 
was  examined at different concentrations of phosphatidic acid, 
cardiolipin, or phosphatidylserine (Fig. 6). Double-reciprocal 
plots of the sn-2-monoC18:l-glycerol  dependence were  linear at 
all concentrations of phosphatidic acid, cardiolipin, or phos- 
phatidylserine  studied,  indicating that MGAT exhibited satu- 
ration  kinetics  with  respect  to  the  concentrations of the mono- 
acylglycerol substrate  in  the absence and presence of added 
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FIG. 5. Effect of neutral lipids on MGAT activity in Triton 
X-100-mixed  micelles. The concentration of lipids in  the MGAT reac- 
tion mixture was vaned as shown.  Control  specific activities obtained in 
the absence of added phospholipid ranged from 63.3 to 71.4 nmol/ 
midmg for the oleic  acid and other curves, respectively. 
phospholipids. The dependence of  MGAT activity on sn-2- 
monoC18:l-glycerol was not cooperative; the calculated Hill 
coefficient of 0.9 did not  vary significantly  with the  addition of 
different concentrations of phosphatidic acid, cardiolipin, or 
phosphatidylserine. 
Addition of each of the phospholipids to the micelle assay 
increased both the  apparent V, and  the  apparent K,. One 
interpretation of these  data is that  the anionic phospholipids 
act at two different sites  to  alter activity, an  allosteric site  that 
increases  the  number of effective enzyme molecules, and a cata- 
lytic site  that reduces the enzyme's affinity for its monoacyl- 
glycerol substrate.  The insets shown in Fig. 5, A-C, are  the 
replots of the 1N intercepts versus l/phosphatidic acid, 
lkardiolipin,  and  l/phosphatidylserine, respectively. The  inter- 
cepts of each  replot  were used  to calculate the concentrations of 
phosphatidic  acid,  cardiolipin, and phosphatidylserine that re- 
sult  in half-maximum activation (K,) of  MGAT activity and  the 
1N intercepts of the  replots  were used to calculate apparent 
V, values of 861,767,  and 398 nmol/min/mg for MGAT in  the 
presence of phosphatidic acid, cardiolipin, and phosphatidyl- 
serine, respectively (Table I ) .  
Effect of Lipid Inhibitors on the Kinetics of MGAT 
Activity-In order  to  determine  the mechanism of inhibition by 
oleic acid and sphingosine, the kinetics of inhibition  were ex- 
amined (Fig. 7). The  ability of each  lipid to  inhibit MGAT was 
similar  in  the presence or absence of phospholipid (see Fig. 5); 
however, because MGAT activity was very low when phospho- 
lipids  were absent,  kinetic  studies  were p rformed in  the pres- 
ence of activating phospholipids. When phosphatidylcholine 
and phosphatidylethanolamine were  present, oleic acid at low 
concentrations  did not  activate MGAT activity (data  not 
shown). MGAT activity  exhibited saturation kinetics  with re- 
spect to sn-2-monoC18:l-glycerol in  the absence or presence of 
oleic acid (Fig. 7A) or sphingosine  (Fig. 7 B )  and  was inhibited 
by oleic acid and sphingosine in a similar concentration-de- 
pendent manner at each sn-2-monoC18:l-glycerol concentra- 
tion. The results obtained from double-reciprocal plots sug- 
gested that the inhibition by  oleic acid or sphingosine is 
noncompetitive or mixed. Thus, each of these  inhibitors may 
interact  with sites that  participate  in both substrate binding 
and catalysis. Areplot of slopes versus the concentration of each 
inhibitor  was  used to calculate apparent K, values (Fig. 7, A and 
B ,  insets). The  apparent K, for oleic acid was 2.4 mol % and for 
sphingosine was 18.3 mol %. Based on these  values, oleic acid 
was a more potent  inhibitor of  MGAT activity than  was  sphin- 
gosine. The calculated Hill coefficient at each oleic acid or 
sphingosine  concentration  did not vary  significantly from the 
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FIG. 6. Effect of phosphatidic  acid (PA), cardiolipin (CL), and 
phosphatidylserine (PS) on the kinetics of MGAT activity in 
mixed  micelles. The concentration of Triton X-100 was 3 m. The 
concentration of the sn-2-monoC18:l-glycerol substrate was vaned as 
indicated. Double-reciprocal plots of the sn-2-monoC18:l-glycerol de- 
pendence of MGAT at  the indicated concentrations of phosphatidic acid 
(A), cardiolipin ( B ) ,  and phosphatidylserine (C) are presented. The 
insets are replots of the l/V intercepts as a function of the reciprocal of 
the respective phospholipid activator concentration with curves calcu- 
lated by a computer-assisted least-squares analysis of the  data. Fkgres- 
sion  coefficients  were greater than 0.974. 
value of l(O.9  and 1.1). 
Table I summarizes  the  kinetic  constants for MGAT. Based 
on the  apparent K, values, phosphatidic acid was a more  potent 
activator  than  was cardiolipin or phosphatidylserine. The  ap- 
parent K, values for these activators were higher than the 
apparent K,,, value for the sn-2-monoC18:l-glycerol substrate 
because, in  the absence of added lipids, MGAT activity was 
saturated at very low concentrations of sn-2-monoC18:l-glyc- 
erol. These studies  suggest  that added  phosphatidic acid, phos- 
phatidylserine, or cardiolipin  each activate MGAT  by a similar 
mechanism. 
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Kinetic  constants for MGAT 
TABLE I 
Unless specified, kinetic values were  calculated from the data in Figs. 6 and 7. 
Activator or 
inhibitor 
Kinetic  constant 
V,, ( a w )  K,(appY K h p )  Kj(appIb 
nmol I min I mg mol % 
None 66.2 * 0.15  0.19 0.07 
PhosDhatidvlcholine  and  uhosuhatidvlserine 682b.' 1.24*,' .~ 






Phosphatidylserine 398 0.73 
Oleic  acid 2.4 
Sphingosine 18.3 
a For sn-2-monoC18:l-glycerol in the absence of phospholipid. 
MGAT activity was measured in the presence of 4.5 mol % phosphatidylcholine  plus 4.5 mol % phosphatidylserine. 
Values  are  derived from data  not  shown elsewhere. 
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FIG. 7. Effect of oleic acid and sphingosine on the kinetics of 
MGAT activity with respect to dependence on sn-2-monoCl81- 
glycerol. MGAT activity was measured at a fixed  Triton X-100 concen- 
tration of 3 mM as a function of various sn-2-monoC18:l-glycerol con- 
centrations. Phosphatidylcholine  and  phosphatidylserine  were present 
at 4.5 mol % each. Oleic  acid (A) and sphingosine ( B )  were  added at the 
indicated concentrations. The data are plotted as l/V (nmoVmidmg) 
uersus the reciprocal  of the sn-2-monoC18:l-glycerol concentration.  The 
inset shows a secondary  plot of the slopes of the lines as a function of the 
inhibitor concentrations. The  curves  drawn  were a result of a computer- 
greater than 0.971. 
assisted least-squares analysis of the data. Regression  coefficients  were 
DISCUSSION 
Hepatic MGAT activity is developmentally  expressed at high 
levels in neonatal rats, with a specific activity as much as 
700-fold higher  during  the suckling period than  in  the  adult. 
Activity peaks on the  sixth  to  ninth  post-natal  days  and de- 
clines to near  adult levels by day  28 (1). During  the suckling 
period, fatty acids provide the major  source of energy, and  rates 
of hepatic P-oxidation are high. Concomitantly, requirements 
for polyunsaturated  fatty acids are increased during  the neo- 
natal period, particularly  in  brain  and  retina (28, 29) despite 
their low availability in rat milk  (30). We have hypothesized 
that  the reacylation of sn-2-monoacylglycero1 by hepatic MGAT 
may slow the oxidation rate of polyunsaturated  fatty acids in 
neonatal  rat  liver (5). 
The activity of most  membrane-bound  enzymes is  dependent 
on, or modulated by, the membrane lipids (31). Our under- 
standing of  how membrane-bound  enzymes are  regulated  has 
been limited by difficulties in  measuring  the effects of phospho- 
lipid cofactors and lipophilic substrates  in  states  that  are physi- 
cally undefined and non-homogeneous. The  use of micellar as- 
says  can overcome these problems. Detergent-mixed micelles 
can effectively solubilize membrane-bound enzymes, thereby 
constituting a  surface of known composition in which the  en- 
zyme can function  (17).  Use of mixed micelles facilitates  the 
presentation of hydrophobic and  amphipathic  substrates, co- 
factors, or modulators to an  enzyme in a physically defined 
system  in which the kinetic properties  can be studied.  Includ- 
ing a low concentration of phospholipid in  the  detergent mi- 
celles does not greatly  disrupt micellar structure (17, 26, 27), 
and endogenous  lipids that  are  present  in solubilized protein 
fractions are subject to surface  dilution and  can be effectively 
eliminated from  consideration  (17). 
Since few microsomal activities of glycerolipid synthesis 
have been purified to homogeneity, information is  still limited 
concerning their  structure,  their  interaction with hydrophobic 
substrates  within  the  plane of the  membrane,  and  their  regu- 
lation. Enzymes of glycerolipid metabolism that have been 
studied  in mixed micelles include  Escherichia coli diacylglyc- 
erol kinase (32), yeast diacylglycerol choline- and ethanola- 
mine-phosphotransferases (331, yeast phosphatidylserine  syn- 
thase and phosphatidylinositol synthase (151, cobra venom 
phospholipase 4 (341, yeast  phosphatidate  phosphatase (161, 
rat liver CTP:phosphocholine cytidyltransferase (351, and  rat 
hepatic  lipase (36). The specific lipids that  modulate protein 
kinase C  activity have also  been  analyzed  (37, 38). 
Purification of MGAT and the use of Triton X-100-mixed 
micelles now allows  detailed characterization of enzyme  acti- 
vation and inhibition by lipid cofactors. MGAT exhibited 
Michaelis-Menton kinetics with respect to monoacylglycerol 
when the substrate concentration was expressed as a mole 
fraction of the mixed micelle. In  the absence of phospholipid, 
the  apparent K,,, for sn-2-Cl8:l-glycerol  was 0.19 mol %. When 
phosphatidylcholine and phosphatidylserine were both pre- 
sent,  the  apparent K, was 1.24 mol %. 
Phospholipid Cofactor Requirement-The data reported here 
clearly demonstrate that specific lipids  modulated hepatic 
MGAT activity in mixed micelles. Although the lipid cofactor 
was  not  an  absolute  requirement for activity, MGAT could be 
activated as much as 11-fold by anionic phospholipids or by 
sn-l,2-diacylglycerol. The  extent of activation by each phospho- 
lipid and lysophospholipid species differed. Anionic phospholip- 
ids were  potent activators  whereas zwitterionic phospholipids 
activated poorly. Kinetic studies  demonstrated  that phospha- 
tidic acid was the  best activator. Although the composition of 
the acyl chain did not  appear  to be critical, the presence of at  
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least one acyl chain  was  required,  suggesting  that activation 
would occur only if the anionic headgroup were  anchored in  the 
micelle. MGAT was  activated  in micelles that contained only a 
single molecule of phosphatidic  acid,  strongly suggesting  that 
activation  requires specific interactions of enzyme and anionic 
headgroup  rather  than merely the presence of a nonspecific 
lipid annulus.  The  remarkable d gree of specificity exhibited by 
different  anionic phospholipids may be related  to differences in 
physical properties of the anionic headgroups and suggests 
that phosphatidic acid and phosphatidylserine could play  spe- 
cific regulatory  roles in  the  synthesis of glycerolipids via the 
monoacylglycerol pathway. 
The few other glycerolipid synthetic enzymes that  have been 
studied  in mixed micelles exhibit  varying  patterns of activa- 
tion. Like MGAT, yeast phosphatidylserine synthase  is potently 
activated by phosphatidic acid in Triton X-100-mixed micelles 
(15). Although phosphatidylinositol also activated phospha- 
tidylserine  synthase, both  cardiolipin and sn-1,2-diacylglycerol 
were both competitive inhibitors (15). The yeast CpTl and 
EPTl gene  products, diacylglycerol choline and  ethanolamine- 
phosphotransferases were activated best by phosphatidylcho- 
line, and phosphatidylinositol was a strong  activator only of the 
cholinephosphotransferase (33). These differences between 
MGAT and  other enzymes studied  in mixed micelles suggest 
that  their  regulatory  sites differ substantially. 
Diacylglycerol Effect-The ability of MGAT's reaction prod- 
uct, sn-l,2-diacylglycerol, to activate MGAT is of particular 
interest.  The  data  suggest  that  an  increase  in  the sn-1,2-dia- 
cylglycerol content of the endoplasmic reticulum would in- 
crease MGAT activity. Although the  hepatic  content of sn-1,2- 
diacylglycerol declines 63% in rats between postnatal days 1 
and 10, the subcellular location of diacylglycerol in hepatocytes 
is not known (39). I t  is possible that diacylglycerol content 
varies  in different  subcellular membranes  and  that  the endo- 
plasmic reticulum  content of diacylglycerol could increase in- 
dependently. 
Although sn-1,2-diacylglycerol was a less potent activator 
than  the anionic  phospholipids, the activation by sn-l,a-diacyl- 
glycerol was highly cooperative. The Hill coefficient of 3.6 sug- 
gests  that sn-1,2 diacylglycerol can  substitute for phospholipid 
activation when relatively  high  concentrations of diacylglycerol 
are  present.  In cellular membranes, however, it is likely that 
diacylglycerol would act  to modulate the effect of anionic phos- 
pholipids. 
Activation was stereospecific for sn-l,2-stereoisomer; the 
diacylglycerol analogs sn-1,3-diC18:l-glycerol, sn-1,2-diC18:1- 
glycerol ether and 1,3-diC18:l-glycerol ether did not affect 
MGAT activity. These specificity data suggest that sn-1,2-di- 
acylglycerol interacts  with a specific enzyme site  rather  than  in 
a nonspecific manner. Diacylglycerol inhibits phosphatidyl- 
serine  synthase from yeast,  but it is  not known whether  inhi- 
bition is stereospecific (15). It was suggested that  the elevated 
diacylglycerol content of stationary  yeast  cultures would  block 
phospholipid synthesis,  thereby favoring the  synthesis of tria- 
cylglycerol (15). Although our  data suggest that sn-l,2-diacyl- 
glycerol may  increase glycerolipid biosynthesis  via the mono- 
acylglycerol pathway, definitive conclusions cannot be drawn 
without  better information on the overall regulation of glycero- 
lipid synthesis  in  neonatal liver. 
Few reports  exist on the  regulation of MGAT  by lipid modu- 
lators. Both phospholipids (1, 6, 20) and sn-1,2-diacylglycerol 
(6) stimulate  neonatal  hepatic MGAT activity in microsomal 
and solubilized preparations.  In  adult rat liver, lysophospha- 
tidic acid and lysophosphatidylethanolamine stimulate MGAT 
activity measured using the activated xenobiotic substrates 
3-phenoxybenzoyl-CoA or 2-hexadecylglycerol(10). In  the  case 
of 2-hexadecylglycerol, it was suggested that  activation may 
of Hepatic MGAT 
have resulted from an  improved dispersal of the emulsified 
substrate (10). 
Our  results strongly suggest  that specific phospholipids, sn- 
1,2-diacylglycerol, fatty acids, and sphingosine could play a 
significant role in  the cellular regulation of MGAT, thereby 
altering  the overall flux of glycerolipid intermediates  and  the 
synthesis of triacylglycerol, phosphatidylcholine, and phos- 
phatidylethanolamine.  Phosphatidic acid is believed to be an 
intracellular second messenger  (38, 40, 41), and  several of the 
putative MGAT regulators, including  phosphatidylserine, fatty 
acids, and sphingosine  also affect the activation of protein ki- 
nase C. Thus,  the  data  presented  here suggest the possibility 
that  regulatory  links  might  exist between signal  transduction 
and  the  synthesis of complex lipids via the monoacylglycerol 
pathway. 
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